游离皮瓣术后选择性应用血糖监测:真实世界实践中的潜在适应证
本研究回顾2017年3月至2021年5月间203例游离皮瓣重建病例,其中35例在临床检查基础上选择性使用血糖测量(BGM)监测皮瓣。结果显示BGM在区分早期充血与真性静脉功能不全、挽救术后监测及放血治疗决策中可能有助于评估皮瓣灌注和决策。
要点
- BGM选择性用于出现红色变和/或毛细血管充盈时间快的皮瓣,以及挽救术后和放血治疗时。
- 29例用BGM区分早期充血与静脉功能不全,所有皮瓣BGM>60 mg/dL,均值115.42,术后经过平稳。
- 3例挽救术后变色皮瓣每3小时测BGM共4次,均值81.6 mg/dL呈上升趋势,皮瓣完全恢复。
核心结论
- 血糖测量可能有助于评估皮瓣灌注并在特定临床情境中辅助决策,可作为皮瓣监测的辅助工具。
研究设计与样本
- 回顾性分析2017年3月至2021年5月间进行的游离皮瓣重建病例中采用BGM监测皮瓣者。
- 共203例游离皮瓣重建,其中35例在临床检查基础上使用BGM监测皮瓣。
主要发现
- 29例用BGM区分早期充血与真性静脉功能不全,所有皮瓣BGM>60 mg/dL,均值115.42,术后经过平稳。
- 3例挽救术后已变色皮瓣每3小时连续测BGM共4次,均值81.6 mg/dL呈上升趋势,皮瓣完全恢复。
- 3例需放血治疗者平均测BGM 11次,中位间隔7小时,当BGM>60 mg/dL且治疗暂停时终止放血,除1例部分坏死外其余皮瓣均成功挽救。
关键数值与推荐
- BGM选择性用于术后即刻出现红色变和/或毛细血管充盈时间快的皮瓣。
- BGM用于挽救术后变色皮瓣的监测。
- BGM用于充血皮瓣挽救性放血治疗时的决策参考,当BGM>60 mg/dL且治疗暂停时终止放血。
临床怎么用
- 作者认为BGM可能有助于评估皮瓣灌注和决策,可作为皮瓣监测的辅助工具。
- 作者认为选择性应用BGM可能有助于实现最佳结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: For free-flap monitoring, physical examination still serves as the criterion standard. Blood glucose measurement (BGM) has been suggested to be useful in identifying flap perfusion status. Nonetheless, its routine use may not be cost-effective in real-world settings. This study aimed to share the experiences of using BGM for flap monitoring and suggest its potential indications. METHODS: Of cases of free flap reconstruction conducted between March 2017 and May 2021, those using BGM for flap monitoring were reviewed. Blood glucose measurement was selectively conducted for the following specific situations, which included encountering a flap showing a reddish discoloration and/or rapid capillary refilling time in the immediate postoperative period, monitoring discolored flaps after conducting a salvage operation, and conducting bloodletting therapy for salvaging congestive flaps. The clinical course and outcomes were evaluated. RESULTS: Of a total of 203 cases, 35 used BGM for flap monitoring in addition to clinical examination. In 29 cases, BGM was performed to distinguish early hyperemia from true venous insufficiency. All flaps showed BGM greater than 60 mg/dL with a mean value of 115.42, suggesting early hyperemia, and had uneventful postoperative courses. In 3 cases with already discolored flaps after a salvage operation, BGM was conducted 4 times serially every 3 hours and showed a mean value of 81.6 mg/dL with increasing trends. The flaps recovered completely. In the other 3 cases requiring bloodletting therapy, BGM was conducted an average of 11 times at a median interval of 7 hours. The bloodletting therapy was terminated with reference to the value of BGM when it showed greater than 60 mg/dL while the therapy was on hold. All flaps were successfully salvaged except one showing partial necrosis. CONCLUSIONS: Blood glucose measurement may be helpful in assessing flap perfusion and decision making in certain clinical situations and may be useful as an ancillary tool for flap monitoring. Selective application of BGM may contribute to achieving optimal outcomes.
引用
- Kim JH, Lee KT. Selective Application of Blood Glucose Monitoring After Free Flap Surgery: Potential Indications in Real-World Practice. Ann Plast Surg. 2023. PMID: 37311313. doi:10.1097/SAP.0000000000003588
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。